All posts by: Michael Zand

About Michael Zand

Mechanism for Resistance to Immunotherapy Treatment Discovered – Newswise (press release)

Continue reading

2018-01-04 NEWS

Mechanism for Resistance to Immunotherapy Treatment Discovered
Newswise (press release)
Newswise — BOSTON – An urgent question for cancer scientists is why immunotherapy achieves dramatic results in some cases but doesn’t help most patients. Now, two research groups from Dana-Farber Cancer Institute have independently discovered a

Continue reading

2018-01-04 NEWS

Medical Xpress

Mechanism for resistance to immunotherapy treatment discovered
Medical Xpress
The scientists’ curiosity was piqued by the fact that ccRCC differs from other types of cancer that respond well to immunotherapy, such as melanoma, non-small cell lung cancer, and a specific type of colorectal cancer. Cells of the latter cancer types

and more »

Continue reading

2018-01-04 NEWS

MIT Technology Review

An $850000 Price Tag on Gene Therapy Shouldn’t Freak You Out—Yet
MIT Technology Review
Mark Trusheim, who directs MIT’s New Drug Development Paradigms program, says gene therapies are moving medicine from a model of “renting” treatments to one of “buying” long-term health improvements. “The challenge is like going from being an apartment
Gene Therapy for Rare Form of Blindness Comes With Nearly $1 Million Price TagTIME
Gene therapy for inherited blindness sets precedent: $850000 price tagWashington Post
Spark Therapeutics Sets Price Of Blindness-Treating Gene Therapy At $850000Forbes
CNN –Rutland Herald –NBCNews.com –CNBC
all 111 news articles »